IGEA Pharma N.V. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net income was EUR 1.32 million compared to net loss of EUR 0.4795 million a year ago. Basic loss per share from continuing operations was EUR 0.0011 compared to EUR 0.0014 a year ago.

Basic earnings per share was EUR 0.0039 compared to basic loss per share of EUR 0.0014 a year ago.